SMALL-BOWEL TRANSPLANTATION - POSTOPERATIVE MANAGEMENT

After initial attempts of small bower transplantations (SBTX), it seem ed evident that the small bower graft is highly susceptible to rejecti on and needs a potent immunosuppressive therapy (1). That fact of matt er remains responsible of the high morbidity after SBTX: a high immuno suppressive therapy leads to a high risk of infection, bacterial infec tion just after surgical procedure and viral of fungal infection in th e late postoperative period. in those cases, the dosage of immunosuppr essive therapy has to be considerably reduced leading to rejection (2) . Rejection often induces a dramatic clinical evolution with severe sh ock. An adequate treatment is to be ordered as soon as possible.